435 related articles for article (PubMed ID: 17870188)
21. Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCR.
Weinberger B; Plentz A; Weinberger KM; Hahn J; Holler E; Jilg W
J Med Virol; 2004 Dec; 74(4):612-8. PubMed ID: 15484273
[TBL] [Abstract][Full Text] [Related]
22. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
23. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction].
Oikawa O
Hokkaido Igaku Zasshi; 1995 Sep; 70(5):729-42. PubMed ID: 8543279
[TBL] [Abstract][Full Text] [Related]
24. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
25. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
[TBL] [Abstract][Full Text] [Related]
26. Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India.
Shukla SK; Prasad KN; Tripathi A; Ghoshal UC; Krishnani N; Husain N
J Med Virol; 2012 Aug; 84(8):1289-97. PubMed ID: 22711358
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Kelly G; Bell A; Rickinson A
Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
[TBL] [Abstract][Full Text] [Related]
28. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
Moran J; Carr M; Waters A; Boyle S; Riordan M; Connell J; Awan A; Hall W; Hassan J
Transplantation; 2011 Aug; 92(3):328-33. PubMed ID: 21685826
[TBL] [Abstract][Full Text] [Related]
29. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
30. Latent and lytic Epstein-Barr virus gene expression in the peripheral blood of astronauts.
Stowe RP; Kozlova EV; Sams CF; Pierson DL; Walling DM
J Med Virol; 2011 Jun; 83(6):1071-7. PubMed ID: 21503923
[TBL] [Abstract][Full Text] [Related]
31. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
Tao Q; Srivastava G; Dickens P; Ho FC
Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
[TBL] [Abstract][Full Text] [Related]
32. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
Zawilinska B; Kosinska A; Lenart M; Kopec J; Piatkowska-Jakubas B; Skotnicki A; Kosz-Vnenchak M
Acta Biochim Pol; 2008; 55(4):693-9. PubMed ID: 19015775
[TBL] [Abstract][Full Text] [Related]
33. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
[TBL] [Abstract][Full Text] [Related]
34. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.
Webster-Cyriaque J; Raab-Traub N
Virology; 1998 Aug; 248(1):53-65. PubMed ID: 9705255
[TBL] [Abstract][Full Text] [Related]
35. [Isolation and characterization of Epstein-Barr virus-infected clones of a human T-lymphoblastoid cell line].
Fujiwara S; Nakamura H; Iwakiri D; Ono Y
Nihon Rinsho; 1997 Feb; 55(2):416-23. PubMed ID: 9046834
[TBL] [Abstract][Full Text] [Related]
36. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
37. Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification.
Liu X; Tang J; Wang M; Ma Q; Wang Y
Int J Mol Sci; 2013 Dec; 14(12):23922-40. PubMed ID: 24351866
[TBL] [Abstract][Full Text] [Related]
38. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
39. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; CarreƱo FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]